Article

Radiopharmaceuticals: Present and Future


 

Commentary on “Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain” by Paes et al. ( page 197)

Conflicts of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.


Correspondence to: Shi-Ming Tu, MD, Department of Genitourinary Medical Oncology, Unit 1374, The University of Texas MD Anderson Cancer Center, P.O. Box 301439, 1155 Pressler Street, Houston, TX 77230-1439; telephone: (713) 563–7268; fax: (713) 745–1625


Vitae

Drs. Atkinson and Tu are from the Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.


The Journal of Supportive Oncology
Volume 9, Issue 6, November-December 2011, Pages 206-207

Pages

Recommended Reading

Does One Size Fit All? Is There a Standard Radiation Dose for Malignant Spinal Cord Compression
MDedge Hematology and Oncology
Guiding Patients Facing Decisions about “Futile” Chemotherapy
MDedge Hematology and Oncology
Obesity May Explain Liver Cancer Hike Among Latinos
MDedge Hematology and Oncology
United States Earns 'B' on Palliative Care Report Card
MDedge Hematology and Oncology
Denosumab Delays Bone Metastases in Castrate-Resistant Prostate Cancer
MDedge Hematology and Oncology
Gabapentin Improved Hot Flashes, Sleep in Postmenopause
MDedge Hematology and Oncology
Community Oncology Podcast - 10 tips for quality improvement in cancer care
MDedge Hematology and Oncology
Most Cancer Patients Want to Discuss Prognosis
MDedge Hematology and Oncology
Patient-centered care and distress screening: tracking the sixth vital sign
MDedge Hematology and Oncology
Screening cancer patients for distress: guidelines for routine implementation
MDedge Hematology and Oncology

Related Articles